Cantor Equity Partners IV, Inc. Class A Ordinary Shares
Cantor Equity Partners IV, Inc. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.
Cantor Equity Partners IV, Inc. Class A Ordinary Shares (CEPF) - Net Assets
Latest net assets as of September 2025: $452.51 Million USD
Based on the latest financial reports, Cantor Equity Partners IV, Inc. Class A Ordinary Shares (CEPF) has net assets worth $452.51 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($452.58 Million) and total liabilities ($72.33K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $452.51 Million |
| % of Total Assets | 99.98% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Cantor Equity Partners IV, Inc. Class A Ordinary Shares - Net Assets Trend (2023–2024)
This chart illustrates how Cantor Equity Partners IV, Inc. Class A Ordinary Shares's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cantor Equity Partners IV, Inc. Class A Ordinary Shares (2023–2024)
The table below shows the annual net assets of Cantor Equity Partners IV, Inc. Class A Ordinary Shares from 2023 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-1.88K | -136.44% |
| 2023-12-31 | $5.16K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cantor Equity Partners IV, Inc. Class A Ordinary Shares's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 704600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $25.00K | % |
| Total Equity | $-1.88K | 100.00% |
Cantor Equity Partners IV, Inc. Class A Ordinary Shares Competitors by Market Cap
The table below lists competitors of Cantor Equity Partners IV, Inc. Class A Ordinary Shares ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jianglong Shipbuilding Co Ltd
SHE:300589
|
$461.28 Million |
|
NGERN TID LOR-NVDR- BA37
F:70V0
|
$461.29 Million |
|
Zhejiang Unifull Industrial Fibre Co Ltd
SHE:002427
|
$461.45 Million |
|
Ocugen Inc
NASDAQ:OCGN
|
$461.52 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
$461.20 Million |
|
Central Plaza Hotel Public Company Limited
BK:CENTEL
|
$461.09 Million |
|
Amplitude Energy Ltd
AU:AEL
|
$461.05 Million |
|
Supply Network Ltd
AU:SNL
|
$460.74 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cantor Equity Partners IV, Inc. Class A Ordinary Shares's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 5,164 to -1,882, a change of -7,046 (-136.4%).
- Net loss of 7,046 reduced equity.
- Other factors decreased equity by 0.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-7.05K | -374.39% |
| Total Change | $- | -136.44% |
Book Value vs Market Value Analysis
This analysis compares Cantor Equity Partners IV, Inc. Class A Ordinary Shares's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2023-12-31 | $0.00 | $10.25 | x |
| 2024-12-31 | $0.00 | $10.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cantor Equity Partners IV, Inc. Class A Ordinary Shares utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-33.62%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2023 | -67.23% | 0.00% | 0.00x | 1.00x | $-3.99K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-6.86K |
Industry Comparison
This section compares Cantor Equity Partners IV, Inc. Class A Ordinary Shares's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $-56,363,212
- Average return on equity (ROE) among peers: -7.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cantor Equity Partners IV, Inc. Class A Ordinary Shares (CEPF) | $452.51 Million | -67.23% | 0.00x | $461.25 Million |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $-22.04K | 0.00% | 0.00x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $5.32 Million | -71.85% | 3.84x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $-185.37K | 0.00% | 0.00x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-181.19K | 0.00% | 0.00x | $14.73K |
| ACRO Biomedical Co Ltd (ACBM) | $-14.79K | 0.00% | 0.00x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-1.02K | 0.00% | 0.00x | $3.15K |